Frontiers in Neurology | Multiple Sclerosis and Neuroimmunology

Original Research

Published on 21 May 2025

Long-term outcomes in leucine-rich glioma inactivated-1 autoimmune encephalitis and associated biomarkers of inflammation and neuronal and glial injury

in Multiple Sclerosis and Neuroimmunology

Tyler L. Borko
Phillip Winters
Kelli M. Money
Stefan Sillau
Sadie Eggmann
Sean Selva
Alanna Ritchie
Ryan Kammeyer
Gregory P. Owens
Jeffrey L. Bennett

Frontiers in Neurology

doi 10.3389/fneur.2025.1583892

3,237 views
1 citation

Original Research

Published on 21 May 2025

Efgartigimod combined with steroids as a fast-acting therapy for anti-SRP immune-mediated necrotizing myopathy

in Multiple Sclerosis and Neuroimmunology

Qiqi Peng
Xiaoping Yao
Sheng Chen
Xiaofeng Li
Feifei Lin
Zhangyu Zou

Frontiers in Neurology

doi 10.3389/fneur.2025.1560483

3,304 views
4 citations

Study Protocol

Published on 16 May 2025

RECLAIM—A retrospective, multicenter observational study aimed at enabling the development of artificial intelligence-driven prognostic models for disease progression in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Jelle Praet
Lina Anderhalten
Giancarlo Comi
Dana Horakova
Tjalf Ziemssen
Patrick Vermersch
Carsten Lukas
Koen Van Leemput
Marjan Steppe
Noemí Manero

Frontiers in Neurology

doi 10.3389/fneur.2025.1557947

3,273 views

Clinical Trial

Published on 09 May 2025

The effects of Leventhal’s self-regulation model-based educational intervention on stress, anxiety, and depression in women with multiple sclerosis: a randomized educational trial

in Multiple Sclerosis and Neuroimmunology

Mahsa Hosseini
Soheila Shamsikhani
Ali Jadidi
Fatemeh Rafiei

Frontiers in Neurology

doi 10.3389/fneur.2025.1521112

2,643 views

Original Research

Published on 09 May 2025

Immune inflammatory regulation in Anti-NMDAR encephalitis: insights from transcriptome analysis

in Multiple Sclerosis and Neuroimmunology

Shan Qiao
Jia Wang
Shan-chao Zhang
Ai-hua Wang
Hai-yun Li
Tao Xin

Frontiers in Neurology

doi 10.3389/fneur.2025.1568274

2,605 views

Correction

Published on 08 May 2025

Corrigendum: Dysphagia in multiple sclerosis: pathophysiology, assessment, and management—an overview

in Multiple Sclerosis and Neuroimmunology

Domenico A. Restivo
Angelo Quartarone
Antongiulio Bruschetta
Angelo Alito
Demetrio Milardi
Rosario Marchese-Ragona
Ennio Iezzi
Sheila Peter
Diego Centonze
Mario Stampanoni Bassi

Frontiers in Neurology

doi 10.3389/fneur.2025.1613012

1,891 views

Original Research

Published on 07 May 2025

Impact of COVID-19 on Guillain Barre Syndrome (GBS) insights from an Iranian referral center

in Multiple Sclerosis and Neuroimmunology

Mohammadali Arami
Rezafarhad Manteghifasaei
Mohammad Karimi
Puya Zandi
Mobina Javadi

Frontiers in Neurology

doi 10.3389/fneur.2025.1565912

3,599 views
1 citation

Original Research

Published on 30 Apr 2025

Frequency and risk factors of sleep problems in Egyptian patients with multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Eman M. Khedr
Gellan K. Ahmed
Shady Safwat Hassan
Mohamed Nageh Foly
Motez Mahmoud Attia
Ahmed A. Karim
Nourelhoda A. Haridy

Frontiers in Neurology

doi 10.3389/fneur.2025.1563041

2,621 views
2 citations

Original Research

Published on 29 Apr 2025

An expert patient program for people living with multiple sclerosis improves knowledge and empowerment: a pre-test, post-test multicenter implementation study

in Multiple Sclerosis and Neuroimmunology

Miguel Ángel Robles-Sánchez
Paloma Amil-Bujan
Cristina Bosch-Farré
Clàudia Coll-Martínez
María Jesús Arévalo
Elisenda Anglada-Clofent
Rebeca Menéndez-Díaz
Montserrat Aroca-Alsina
Miguel Merchan-Ruiz
Santiago Pérez-Hoyos

Frontiers in Neurology

doi 10.3389/fneur.2025.1581038

3,200 views

Original Research

Published on 28 Apr 2025

Immunotherapy for neuromyelitis optica spectrum disorder: a comparative analysis of efficacy and safety of azathioprine, mycophenolate mofetil, tacrolimus, and rituximab

in Multiple Sclerosis and Neuroimmunology

Jing Zhou
Xiaolin Yang
Xinyi Wang
Bin Li
Yun Xu
Haoran Zhang
Yinxin Zhu
Xiaoming Wang
Jinzhou Feng

Frontiers in Neurology

doi 10.3389/fneur.2025.1559118

5,083 views
3 citations

Original Research

Published on 28 Apr 2025

Resolution of anti-GAD-associated autoimmune encephalitis in patients treated with efgartigimod

in Multiple Sclerosis and Neuroimmunology

Min Chen
Zhuajin Bi
Wenzhong Kang
Ruihan Liu
Liu Hongbo
Yan Jiang
Qun Wang

Frontiers in Neurology

doi 10.3389/fneur.2025.1550023

3,608 views

Original Research

Published on 16 Apr 2025

Raman liquid biopsy: a new approach to the multiple sclerosis diagnostics

in Multiple Sclerosis and Neuroimmunology

Anna Neupokoeva
Ivan Bratchenko
Lyudmila Bratchenko
Elena Khivintseva
Igor Shirolapov
Natalia Shusharina
Matvei Khoimov
Valery Zakharov
Alexander Zakharov

Frontiers in Neurology

doi 10.3389/fneur.2025.1516712

2,260 views
1 citation

Original Research

Published on 15 Apr 2025

Disparities in patient share and characteristics between disease-modifying therapy-treated and -untreated people with multiple sclerosis in Germany: a claims data analysis from 2017 to 2022

in Multiple Sclerosis and Neuroimmunology

Ann-Sophie Stratil
Steffeni Papukchieva
Nils-Henning Neß
Inge Wolf
Antonios Bayas
Peter Flachenecker
Benjamin Friedrich

Frontiers in Neurology

doi 10.3389/fneur.2025.1561810

2,854 views

Case Report

Published on 10 Apr 2025

Very-late-onset neuromyelitis optica spectrum disorder: a case report and review

in Multiple Sclerosis and Neuroimmunology

Rui-Ting Liu
Yu-Kun Guo
Xia Du
Heng Li

Frontiers in Neurology

doi 10.3389/fneur.2025.1559872

3,970 views
1 citation

Editorial

Published on 03 Apr 2025

Editorial: Spatial transcriptome and single-cell sequencing for exploring molecular mechanisms of neuroimmunity and discovering novel markers of neurological diseases

in Multiple Sclerosis and Neuroimmunology

Bowen Wang
Yachen Shi
Chao Cheng
Jian Song
Yuanbo Pan

Frontiers in Neurology

doi 10.3389/fneur.2025.1582019

1,937 views

Original Research

Published on 02 Apr 2025

Isolated cranial nerve disorder as presenting sign in multiple sclerosis: optic nerve versus “the others”

in Multiple Sclerosis and Neuroimmunology

Arianna Di Stadio
Pietro Scribani Rossi
Diego Kaski
Chiara Zilli
Massimo Ralli
Evanthia Bernitsas
Marta Altieri

Frontiers in Neurology

doi 10.3389/fneur.2025.1557326

2,616 views

Perspective

Published on 28 Mar 2025

Steps toward the implementation of neurofilaments in multiple sclerosis: patient profiles to be prioritized in clinical practice

in Multiple Sclerosis and Neuroimmunology

Diego Centonze
Alessia Di Sapio
Vincenzo Brescia Morra
Elena Colombo
Matilde Inglese
Damiano Paolicelli
Marco Salvetti
Roberto Furlan

Frontiers in Neurology

doi 10.3389/fneur.2025.1571605

3,137 views
4 citations

Original Research

Published on 26 Mar 2025

Electroencephalographic biomarkers of antibody-mediated autoimmune encephalitis

in Multiple Sclerosis and Neuroimmunology

Lu Sun
Yaping Hu
Jingjing Yang
Lihong Chen
Ying Wang
Wei Liu
Jau-Shyong Hong
Yunhui Lv
Lin Yang
Ying Wang

Frontiers in Neurology

doi 10.3389/fneur.2025.1510722

4,489 views
2 citations

Original Research

Published on 25 Mar 2025

Rituximab treatment in Chinese patients with primary angiitis of the central nervous system

in Multiple Sclerosis and Neuroimmunology

Yu-Zhen Wei
Hua-Bing Wang
Lin-Lin Yin
Ai Guo
Lu-lin Zhang
Jia-Li Sun
Ping Lu
Xing-Hu Zhang
De-Cai Tian

Frontiers in Neurology

doi 10.3389/fneur.2025.1554989

2,084 views

Original Research

Published on 17 Mar 2025

Cognitive-motor interference in multiple sclerosis revisited: a dual-task paradigm using wearable inertial sensors and the Paced Auditory Serial Addition Test

in Multiple Sclerosis and Neuroimmunology

Lea Kremer
Lucas Schreff
Daniel Hamacher
Patrick Oschmann
Veit Rothhammer
Philipp M. Keune
Roy Müller

Frontiers in Neurology

doi 10.3389/fneur.2025.1546183

2,999 views
3 citations

Original Research

Published on 12 Mar 2025

Efficacy of dexamethasone combined with intravenous immunoglobulin for the treatment of pediatric autoimmune encephalitis

in Multiple Sclerosis and Neuroimmunology

Xiaolin Zhou
Xiangyang Luo
Zhanwen He
Danxia Tang
Yu Li
Pinggan Li

Frontiers in Neurology

doi 10.3389/fneur.2025.1512908

3,109 views
1 citation

Original Research

Published on 28 Feb 2025

The clinical value of the neutrophil-to-lymphocyte ratio, systemic immune-inflammation index, monocyte-to-lymphocyte ratio and platelet-to-lymphocyte ratio for predicting the severity of patients with autoimmune encephalitis

in Multiple Sclerosis and Neuroimmunology

Xin Zhao
Fen Wu
Shunfeng Zhao
Wenna Chen
Wei Si
Yuanrui Li
Dengke Zhang
Jing Wang
Ningning Wang
Lina Sun

Frontiers in Neurology

doi 10.3389/fneur.2025.1498007

2,904 views
2 citations

Review

Published on 18 Feb 2025

Leber’s hereditary optic neuropathy and multiple sclerosis: overlap between mitochondrial disease and neuroinflammation

in Multiple Sclerosis and Neuroimmunology

Golbarg Rahimi
Mackenzie Silverman
Maeve Lucas
Lilia Kazerooni
Mariam M. Yousuf
Saba Jafarpour
Jonathan D. Santoro

Frontiers in Neurology

doi 10.3389/fneur.2025.1538358

4,561 views
3 citations

Original Research

Published on 17 Feb 2025

Alterations in neutrophil mRNA profiles in multiple sclerosis and identification of candidate genes for further investigation

in Multiple Sclerosis and Neuroimmunology

Huining Zhang
Ruoyi Guo
Yusen Han
Zhichao Yao
Moyuan Quan
Bin Li
Li Guo

Frontiers in Neurology

doi 10.3389/fneur.2025.1548196

3,481 views

1,192 articles

articles

Long-term outcomes in leucine-rich glioma inactivated-1 autoimmune encephalitis and associated biomarkers of inflammation and neuronal and glial injury

Efgartigimod combined with steroids as a fast-acting therapy for anti-SRP immune-mediated necrotizing myopathy

RECLAIM—A retrospective, multicenter observational study aimed at enabling the development of artificial intelligence-driven prognostic models for disease progression in multiple sclerosis

The effects of Leventhal’s self-regulation model-based educational intervention on stress, anxiety, and depression in women with multiple sclerosis: a randomized educational trial

Immune inflammatory regulation in Anti-NMDAR encephalitis: insights from transcriptome analysis

Corrigendum: Dysphagia in multiple sclerosis: pathophysiology, assessment, and management—an overview

Impact of COVID-19 on Guillain Barre Syndrome (GBS) insights from an Iranian referral center

Frequency and risk factors of sleep problems in Egyptian patients with multiple sclerosis

An expert patient program for people living with multiple sclerosis improves knowledge and empowerment: a pre-test, post-test multicenter implementation study

Immunotherapy for neuromyelitis optica spectrum disorder: a comparative analysis of efficacy and safety of azathioprine, mycophenolate mofetil, tacrolimus, and rituximab

Resolution of anti-GAD-associated autoimmune encephalitis in patients treated with efgartigimod

Raman liquid biopsy: a new approach to the multiple sclerosis diagnostics

Disparities in patient share and characteristics between disease-modifying therapy-treated and -untreated people with multiple sclerosis in Germany: a claims data analysis from 2017 to 2022

Very-late-onset neuromyelitis optica spectrum disorder: a case report and review

Editorial: Spatial transcriptome and single-cell sequencing for exploring molecular mechanisms of neuroimmunity and discovering novel markers of neurological diseases

Isolated cranial nerve disorder as presenting sign in multiple sclerosis: optic nerve versus “the others”

Steps toward the implementation of neurofilaments in multiple sclerosis: patient profiles to be prioritized in clinical practice

Electroencephalographic biomarkers of antibody-mediated autoimmune encephalitis

Rituximab treatment in Chinese patients with primary angiitis of the central nervous system

Cognitive-motor interference in multiple sclerosis revisited: a dual-task paradigm using wearable inertial sensors and the Paced Auditory Serial Addition Test

Efficacy of dexamethasone combined with intravenous immunoglobulin for the treatment of pediatric autoimmune encephalitis

The clinical value of the neutrophil-to-lymphocyte ratio, systemic immune-inflammation index, monocyte-to-lymphocyte ratio and platelet-to-lymphocyte ratio for predicting the severity of patients with autoimmune encephalitis

Leber’s hereditary optic neuropathy and multiple sclerosis: overlap between mitochondrial disease and neuroinflammation

Alterations in neutrophil mRNA profiles in multiple sclerosis and identification of candidate genes for further investigation